ArticleFunctional & integrative genomics2026
GABPB1 activates transcription of ITPR3 and EMT in OSCC progression.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The five-year survival rate of patients diagnosed with oral squamous cell carcinoma (OSCC) is less than 60%, mainly because of tumor metastasis and recurrence. The metastasis of cancer from the primary site is a complex process known as epithelial-mesenchymal transition (EMT). In this study, we examined the function of ITPR3 in EMT in OSCC. OSCC cells were infected with sh-ITPR3 lentivirus, and the effect of ITPR3 knockdown was assessed. An in vivo model was constructed by subcutaneous injection of SCC15 cells into nude mice to detect the effect of ITPR3 on OSCC tumor growth. The upstream mechanism of elevated ITPR3 expression was analyzed using bioinformatics. ITPR3 and GABPB1 were overexpressed in OSCC tissue and cells. ITPR3 knockdown inhibited epithelial-mesenchymal transition (EMT) and tumor growth in vivo. GABPB1 activated ITPR3 transcription by binding to its promoter. ITPR3-mediated calcium ion release activated the expression of the oncogenic factor RELB and the phosphorylation of ERK within OSCC cells. Knockdown of GABPB1 inhibited OSCC progression, which was negated by ITPR3 overexpression. In summary, this study elucidates that GABPB1 activates ITPR3 transcription, thereby inducing EMT in OSCC.
Indexed as
Identifiers
41663849What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.